Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis
2016
Schiff bases: A short review of their antimicrobial activities
2010 Standout
Leishmaniasis
2018 Standout
Disruption of response regulator gene,devR, leads to attenuation in virulence ofMycobacterium tuberculosis
2004
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
The clinical consequences of strain diversity in Mycobacterium tuberculosis
2008
The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling Model
2007
Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
2014
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Does M. tuberculosis genomic diversity explain disease diversity?
2010
Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development
2007
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose
2007 Standout
Radioprotective effects of black seed (Nigella sativa) oil against hemopoietic damage and immunosuppression in gamma-irradiated rats
2010
Expression of katG in Mycobacterium tuberculosis Is Associated with Its Growth and Persistence in Mice and Guinea Pigs
1998
Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base
2004
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
2020 StandoutNature
Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
2012
Pathogenesis of tuberculosis: pathway to apical localization
1994
A Novel Pathogenic Taxon of the Mycobacterium tuberculosis Complex, Canetti: Characterization of an Exceptional Isolate from Africa
1997
Pharmacology of oleanolic acid and ursolic acid
1995 Standout
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis
2013
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
A review on therapeutic potential of Nigella sativa: A miracle herb
2013 Standout
The Growing Burden of Tuberculosis
2003 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Control of Tuberculosis
1967
Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro
1994
The biological cost of antibiotic resistance
1999 Standout
Electron Microscopic Observations on the Excretion of Cell-wall Material by Vibrio cholerae
1967
Mycobacterial virulence factors.
1996
A Review of Computer Vision Techniques for the Analysis of Urban Traffic
2011 Standout
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
1995
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Hepatoprotective activity in the rat of ursolic acid isolated from eucalyptus hybrid
1992
Epidemiologic basis of tuberculosis control
1999
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from India
2001
Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India
2013
Analysis of Rain and Snow in Frequency Space
2009
Plasma and salivary concentrations of isoniazid in man: Preliminary findings in two slow acetylator subjects
1975
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
2010
Host–pathogen coevolution in human tuberculosis
2012
Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
2015
Mycobacterial virulence factors
1996
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
1980 Standout
rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
2003 Standout
The Immune Response in Tuberculosis
2013 Standout
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
2002
Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues
1990 Standout
A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.
1969
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Infectiousness of pulmonary tuberculosis after starting chemotherapy
1981
A new evolutionary scenario for the Mycobacterium tuberculosis complex
2002 Standout
The Continuing Challenges of Leprosy
2006 Standout
Works of Ankit Bhatia being referenced
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.
1961
The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.
1962
Choleragenic property of lipopolysaccharide fraction from Vibrio cholerae Inaba.
1966
Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India
2011
A comparison of the virulence in Guinea-pigs of south indian and British tubercle bacilli
1960
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy.
1961
A spectral-particle hybrid method for rendering falling snow
2004
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test.
1961
Development of paracetamol induced hepatocellular tolerance in albino rats.
1988
A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy
1963
Hematocytometrical Changes In Swiss Albino Mice After Intrauterine Low-Level HTO-Exposure
1986
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 2. Comparison with virulence of tubercle bacilli from British patients.
1961
The virulence in the guinea-pig of isoniazid-sensitive tubercle bacilli isolated from South Indian patients before treatment and after three months of chemotherapy.
1961
A comparison of the sensitivity to p-aminosalicylic acid of tubercle bacilli from South Indian and British patients.
1960
The virulence of South Indian tubercle bacilli in mice and guinea-pigs infected by the intravenous route
1961
Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.
1961